Company / Revenue per Share
Merck & Co. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$25.52
FY2025
5-year range
$18.88 / $25.52
FY2021-FY2025
Trend
+1.1%
vs FY2024
Sector context
#20 of 154
Health Care
What the data says
Merck & Co.'s revenue per share of $25.52 is higher than 87% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 6 consecutive years, from $14.24 in FY2019 to $25.52 in FY2025.
Based on SEC 10-K filings.
25.52 in FY2025 with a 5-year CAGR of +10.5%. Top quartile in the Health Care sector.
Improved from $23.69 to $25.52 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- +10.5%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 154This company $25.52 Sector average $15.09
▼
+69.1% above sector average
Key checks
Key Insights
- Merck & Co.'s revenue per share has grown for 6 consecutive years.
- In FY2025, revenue per share increased 1.1% year-over-year.
- Ranks #20 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.52 | +1.1% |
| FY2024 | $25.24 | +6.6% |
| FY2023 | $23.69 | +1.5% |
| FY2022 | $23.33 | +23.6% |
| FY2021 | $18.88 | +21.8% |
| FY2020 | $15.50 | +8.9% |
| FY2019 | $14.24 | -6.2% |
| FY2018 | $15.18 | +7.5% |
| FY2017 | $14.12 | +3.9% |
| FY2016 | $13.60 | +3.1% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026